{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:38:55Z","timestamp":1793090335214,"version":"4.5.0"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32260014"],"award-info":[{"award-number":["32260014"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.critrevonc.2026.105622","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:03:26Z","timestamp":1790435006000},"page":"105622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting nicotinamide metabolism to reprogram the tumor microenvironment: Mechanisms and novel therapeutic strategies"],"prefix":"10.1016","volume":"227","author":[{"given":"Wei-Dong","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang-Zhou","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Juan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Yan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9221-0387","authenticated-orcid":false,"given":"Jiang-Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2026.105622_bib1","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/cvr\/cvm111","article-title":"Visfatin induces human endothelial VEGF and MMP-2\/9 production via MAPK and PI3K\/akt signalling pathways: novel insights into visfatin-induced angiogenesis","volume":"78","author":"Adya","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.critrevonc.2026.105622_bib2","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1080\/01443615.2020.1854696","article-title":"Small molecule inhibitor of nicotinamide N-methyltransferase shows anti-proliferative activity in HeLa cells","volume":"41","author":"Akar","year":"2021","journal-title":"J. Obstet. Gynaecol."},{"key":"10.1016\/j.critrevonc.2026.105622_bib3","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.semcdb.2019.05.001","article-title":"Targeting metabolic reprogramming in metastatic melanoma: The key role of nicotinamide phosphoribosyltransferase (NAMPT)","volume":"98","author":"Audrito","year":"2020","journal-title":"Semin. Cell. Dev. Biol."},{"key":"10.1016\/j.critrevonc.2026.105622_bib4","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3389\/fonc.2020.00358","article-title":"NAMPT and NAPRT: two metabolic enzymes with key roles in inflammation","volume":"10","author":"Audrito","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105622_bib5","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.omtn.2018.03.011","article-title":"Targeting Nicotinamide N-Methyltransferase and miR-449a in EGFR-TKI-Resistant Non-Small-Cell Lung Cancer Cells","volume":"11","author":"Bach","year":"2018","journal-title":"Mol. Ther. - Nucleic Acids"},{"key":"10.1016\/j.critrevonc.2026.105622_bib6","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13046-016-0389-9","article-title":"1-methylnicotinamide and its structural analog 1,4-dimethylpyridine for the prevention of cancer metastasis","volume":"35","author":"Blazejczyk","year":"2016","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105622_bib7","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1038\/s41467-020-17644-0","article-title":"Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer","volume":"11","author":"Buqu\u00e9","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105622_bib8","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1249\/MSS.0000000000002116","article-title":"Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable","volume":"51","author":"Campbell","year":"2019","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.critrevonc.2026.105622_bib9","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1158\/1078-0432.CCR-13-0150","article-title":"Targeting of NAD metabolism in pancreatic cancer cells: potential novel therapy for pancreatic tumors","volume":"20","author":"Chini","year":"2014","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105622_bib10","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1734-1140(12)70777-6","article-title":"Single bout of endurance exercise increases NNMT activity in the liver and MNA concentration in plasma; the role of IL-6","volume":"64","author":"Ch\u0142opicki","year":"2012","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.critrevonc.2026.105622_bib11","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s41586-019-1150-2","article-title":"NAD metabolic dependency in cancer is shaped by gene amplification and enhancer remodelling","volume":"569","author":"Chowdhry","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105622_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1285516","article-title":"Diet-driven microbiome changes and physical activity in cancer patients","volume":"10","author":"Ciernikova","year":"2023","journal-title":"Front. Nutr."},{"key":"10.1016\/j.critrevonc.2026.105622_bib13","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00109-020-01892-0","article-title":"Neutralization of extracellular NAMPT (nicotinamide phosphoribosyltransferase) ameliorates experimental murine colitis","volume":"98","author":"Colombo","year":"2020","journal-title":"J. Mol. Med. Berl. Ger."},{"key":"10.1016\/j.critrevonc.2026.105622_bib14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12943-025-02285-y","article-title":"NNMT promotes acquired EGFR-TKI resistance by forming EGR1 and lactate-mediated double positive feedback loops in non-small cell lung cancer","volume":"24","author":"Dai","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105622_bib15","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.metabol.2018.01.001","article-title":"The role of extracellular and intracellular nicotinamide phosphoribosyl-transferase in cancer: diagnostic and therapeutic perspectives and challenges","volume":"82","author":"Dalamaga","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.critrevonc.2026.105622_bib16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cell.2018.02.008","article-title":"Impairment of an endothelial NAD+-H2S signaling network is a reversible cause of vascular aging","volume":"173","author":"Das","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105622_bib17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12192-019-01063-2","article-title":"\u03b1-mangostin reduced the viability of A594 cells in vitro by provoking ROS production through downregulation of NAMPT\/NAD","volume":"25","author":"Ding","year":"2020","journal-title":"Cell. Stress. Chaperon-.-."},{"key":"10.1016\/j.critrevonc.2026.105622_bib18","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3892\/or.2014.3661","article-title":"Nicotinamide sensitizes human breast cancer cells to the cytotoxic effects of radiation and cisplatin","volume":"33","author":"Dom\u00ednguez-G\u00f3mez","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.critrevonc.2026.105622_bib19","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41586-019-1173-8","article-title":"Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts","volume":"569","author":"Eckert","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105622_bib20","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nature19364","article-title":"Ionic immune suppression within the tumour microenvironment limits T cell effector function","volume":"537","author":"Eil","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105622_bib21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s13046-026-03734-2","article-title":"Bi-directional regulation between NAD\/NAMPT and IFN-\u03b3\/PD-L1 axes via BRD4\/IRF1 and mitochondrial respiration in metastatic cutaneous melanoma","volume":"45","author":"Fiorilla","year":"2026","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105622_bib22","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.biochi.2011.06.033","article-title":"Characterization of human nicotinate phosphoribosyltransferase: kinetic studies, structure prediction and functional analysis by site-directed mutagenesis","volume":"94","author":"Galassi","year":"2012","journal-title":"Biochimie"},{"key":"10.1016\/j.critrevonc.2026.105622_bib23","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3389\/fphar.2020.00656","article-title":"Recent advances in NAMPT inhibitors: a novel immunotherapic strategy","volume":"11","author":"Galli","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.critrevonc.2026.105622_bib24","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1165\/rcmb.2021-0357OC","article-title":"eNAMPT is a novel damage-associated molecular pattern protein that contributes to the severity of radiation-induced lung fibrosis","volume":"66","author":"Garcia","year":"2022","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"10.1016\/j.critrevonc.2026.105622_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2022.106189","article-title":"NAMPT: a critical driver and therapeutic target for cancer","volume":"145","author":"Gasparrini","year":"2022","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"10.1016\/j.critrevonc.2026.105622_bib26","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1128\/MMBR.00042-08","article-title":"Microbial NAD metabolism: lessons from comparative genomics","volume":"73","author":"Gazzaniga","year":"2009","journal-title":"Microbiol. Mol. Biol. Rev. MMBR"},{"key":"10.1016\/j.critrevonc.2026.105622_bib27","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.3390\/nu13051665","article-title":"Advances in NAD-lowering agents for cancer treatment","volume":"13","author":"Ghanem","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.critrevonc.2026.105622_bib28","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/s12964-025-02361-2","article-title":"NAMPT and NNMT released via extracellular vesicles and as soluble mediators are distinguished traits of BRAF inhibitor resistance of melanoma cells impacting on the tumor microenvironment","volume":"23","author":"Ghezzi","year":"2025","journal-title":"Cell. Commun. Signal."},{"key":"10.1016\/j.critrevonc.2026.105622_bib29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.aan4236","article-title":"Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients","volume":"359","author":"Gopalakrishnan","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2026.105622_bib30","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105622_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-025-09303-5","article-title":"NNMT inhibition in cancer-associated fibroblasts restores antitumour immunity","author":"Heide","year":"2025","journal-title":"Nature 19"},{"key":"10.1016\/j.critrevonc.2026.105622_bib32","article-title":"NAMPT-driven M2 polarization of tumor-associated macrophages leads to an immunosuppressive microenvironment in colorectal cancer","volume":"11","author":"Hong","year":"2024","journal-title":"Adv. Sci. Weinh. Baden. -Wurtt. Ger."},{"key":"10.1016\/j.critrevonc.2026.105622_bib33","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1038\/s41467-021-22923-5","article-title":"A Stat1 bound enhancer promotes nampt expression and function within tumor associated macrophages","volume":"12","author":"Huffaker","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105622_bib34","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tcb.2014.04.002","article-title":"NAD+ and sirtuins in aging and disease","volume":"24","author":"Imai","year":"2014","journal-title":"Trends Cell. Biol."},{"key":"10.1016\/j.critrevonc.2026.105622_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2025.119994","article-title":"Metabolomic profiling reveals grade-specific niacinamide accumulation and its therapeutic potential via SIRT1-CD38-EMT axis modulation in cervical cancer progression","volume":"1872","author":"Jaiswal","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. Cell. Res."},{"key":"10.1016\/j.critrevonc.2026.105622_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2024.05.013","article-title":"Nicotinamide metabolism face-off between macrophages and fibroblasts manipulates the microenvironment in gastric cancer","author":"Jiang","year":"2024","journal-title":"Cell. Metab."},{"key":"10.1016\/j.critrevonc.2026.105622_bib37","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1002\/1878-0261.13209","article-title":"Nicotinamide (niacin) supplement increases lipid metabolism and ROS-induced energy disruption in triple-negative breast cancer: potential for drug repositioning as an anti-tumor agent","volume":"16","author":"Jung","year":"2022","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105622_bib38","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.1158\/0008-5472.CAN-19-1405","article-title":"BRCA1 Deficiency Upregulates NNMT, Which Reprograms Metabolism and Sensitizes Ovarian Cancer Cells to Mitochondrial Metabolic Targeting Agents","volume":"79","author":"Kanakkanthara","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105622_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe1174","article-title":"1-Methylnicotinamide is an immune regulatory metabolite in human ovarian cancer","volume":"7","author":"Kilgour","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.critrevonc.2026.105622_bib40","doi-asserted-by":"crossref","first-page":"573","DOI":"10.18632\/aging.101414","article-title":"An epigenetic biomarker of aging for lifespan and healthspan","volume":"10","author":"Levine","year":"2018","journal-title":"Aging"},{"key":"10.1016\/j.critrevonc.2026.105622_bib41","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3390\/biom11091295","article-title":"Curcumin Reverses NNMT-Induced 5-Fluorouracil Resistance via Increasing ROS and Cell Cycle Arrest in Colorectal Cancer Cells","volume":"11","author":"Li","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.critrevonc.2026.105622_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/or.2021.8061","article-title":"Vanillin downregulates NNMT and attenuates NNMT\u2011related resistance to 5\u2011fluorouracil via ROS\u2011induced cell apoptosis in colorectal cancer cells","volume":"45","author":"Li","year":"2021","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.critrevonc.2026.105622_bib43","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3970605","article-title":"Role of nampt and visceral adiposity in esophagogastric junction adenocarcinoma","volume":"2017","author":"Li","year":"2017","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.critrevonc.2026.105622_bib44","doi-asserted-by":"crossref","first-page":"5024","DOI":"10.1158\/0008-5472.CAN-20-1094","article-title":"Local targeting of NAD+ salvage pathway alters the immune tumor microenvironment and enhances checkpoint immunotherapy in glioblastoma","volume":"80","author":"Li","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105622_bib45","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The warburg effect: how does it benefit cancer cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.critrevonc.2026.105622_bib46","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.3390\/cancers14092059","article-title":"Updated functional roles of NAMPT in carcinogenesis and therapeutic niches","volume":"14","author":"Lin","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105622_bib47","doi-asserted-by":"crossref","first-page":"25758","DOI":"10.1074\/jbc.M112.362343","article-title":"NAD+-dependent sirtuin 1 and 6 proteins coordinate a switch from glucose to fatty acid oxidation during the acute inflammatory response","volume":"287","author":"Liu","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.critrevonc.2026.105622_bib48","doi-asserted-by":"crossref","first-page":"656","DOI":"10.4149\/neo_2018_171024N680","article-title":"Nicotinamide N-methyltransferase as a potential marker for cancer","volume":"65","author":"Lu","year":"2018","journal-title":"Neoplasma"},{"key":"10.1016\/j.critrevonc.2026.105622_bib49","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cmet.2020.10.021","article-title":"NAD+ metabolism maintains inducible PD-L1 expression to drive tumor immune evasion","volume":"33","author":"Lv","year":"2021","journal-title":"Cell. Metab."},{"key":"10.1016\/j.critrevonc.2026.105622_bib50","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1126\/science.abc3421","article-title":"Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy","volume":"369","author":"Mager","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2026.105622_bib51","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fgene.2015.00148","article-title":"Systematic genome assessment of B-vitamin biosynthesis suggests co-operation among gut microbes","volume":"6","author":"Magn\u00fasd\u00f3ttir","year":"2015","journal-title":"Front. Genet."},{"key":"10.1016\/j.critrevonc.2026.105622_bib52","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1039\/c9pp00388f","article-title":"Nicotinamide for skin cancer chemoprevention: effects of nicotinamide on melanoma in vitro and in vivo","volume":"19","author":"Malesu","year":"2020","journal-title":"Photochem. Photobiol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105622_bib53","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1158\/1078-0432.CCR-23-0200","article-title":"Inhibition of NAD+-dependent metabolic processes induces cellular necrosis and tumor regression in rhabdomyosarcoma models","volume":"29","author":"McKay-Corkum","year":"2023","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105622_bib54","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1158\/1535-7163.MCT-24-0225","article-title":"Targeting NAD+ metabolism vulnerability in FH-deficient hereditary leiomyomatosis and renal cell carcinoma with the novel NAMPT inhibitor OT-82","volume":"24","author":"Najera","year":"2025","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.critrevonc.2026.105622_bib55","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s00018-025-05641-9","article-title":"Nicotinamide metabolism reprogramming drives reversible senescence of glioblastoma cells","volume":"82","author":"Narayanan","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.critrevonc.2026.105622_bib56","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41392-020-00354-w","article-title":"NAD+ metabolism, stemness, the immune response, and cancer","volume":"6","author":"Navas","year":"2021","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.critrevonc.2026.105622_bib57","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3390\/biom10030477","article-title":"The Role of Nicotinamide in Cancer Chemoprevention and Therapy","volume":"10","author":"Nikas","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.critrevonc.2026.105622_bib58","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.21873\/anticanres.16964","article-title":"Gastric Cancer With the Increased Nicotinamide N-methyltransferase-positive Stromal Cells Includes Unfavorable Prognosis-related Cancer-associated Fibroblasts","volume":"44","author":"Numakura","year":"2024","journal-title":"Anticancer. Res."},{"key":"10.1016\/j.critrevonc.2026.105622_bib59","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1165\/rcmb.2017-0155OC","article-title":"Novel mechanism for nicotinamide phosphoribosyltransferase inhibition of TNF-\u03b1-mediated apoptosis in human lung endothelial cells","volume":"59","author":"Oita","year":"2018","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"10.1016\/j.critrevonc.2026.105622_bib60","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s12272-024-01519-9","article-title":"Exploring NNMT: from metabolic pathways to therapeutic targets","volume":"47","author":"Park","year":"2024","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.critrevonc.2026.105622_bib61","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.cmet.2016.01.011","article-title":"Voluntary running suppresses tumor growth through epinephrine- and IL-6-dependent NK cell mobilization and redistribution","volume":"23","author":"Pedersen","year":"2016","journal-title":"Cell. Metab."},{"key":"10.1016\/j.critrevonc.2026.105622_bib62","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.tem.2017.02.004","article-title":"Nicotinamide N -methyltransferase: more than a vitamin B3 clearance enzyme","volume":"28","author":"Pissios","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2026.105622_bib63","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ijc.31808","article-title":"NAMPT signaling is critical for the proangiogenic activity of tumor-associated neutrophils","volume":"144","author":"Pylaeva","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105622_bib64","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02536-2020","article-title":"Endothelial eNAMPT amplifies pre-clinical acute lung injury: efficacy of an eNAMPT-neutralising monoclonal antibody","volume":"57","author":"Quijada","year":"2021","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.critrevonc.2026.105622_bib65","article-title":"Exploring nicotinamide adenine dinucleotide precursors across biosynthesis pathways: unraveling their role in the ovary","volume":"38","author":"Ren","year":"2024","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.critrevonc.2026.105622_bib66","doi-asserted-by":"crossref","first-page":"5386","DOI":"10.1038\/s41598-020-62190-w","article-title":"Visfatin\/eNampt induces endothelial dysfunction in vivo: a role for toll-like receptor 4 and NLRP3 inflammasome","volume":"10","author":"Romacho","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105622_bib67","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2026.105622_bib68","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pharmthera.2015.02.004","article-title":"Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer","volume":"151","author":"Sampath","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.critrevonc.2026.105622_bib69","doi-asserted-by":"crossref","first-page":"65429","DOI":"10.18632\/oncotarget.11748","article-title":"Tumor vessel normalization after aerobic exercise enhances chemotherapeutic efficacy","volume":"7","author":"Schadler","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2026.105622_bib70","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/neuonc\/noab175","article-title":"Inhibition of nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme of the nicotinamide adenine dinucleotide (NAD) salvage pathway, to target glioma heterogeneity through mitochondrial oxidative stress","volume":"24","author":"Sharma","year":"2022","journal-title":"Neuro-Oncol."},{"key":"10.1016\/j.critrevonc.2026.105622_bib71","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41389-018-0064-4","article-title":"NNMT depletion contributes to liver cancer cell survival by enhancing autophagy under nutrient starvation","volume":"7","author":"Shin","year":"2018","journal-title":"Oncogenesis"},{"key":"10.1016\/j.critrevonc.2026.105622_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103059","article-title":"Role of secreted extracellular nicotinamide phosphoribosyltransferase (eNAMPT) in prostate cancer progression: novel biomarker and therapeutic target","volume":"61","author":"Sun","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.critrevonc.2026.105622_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113208","article-title":"Nicotinamide N-methyltransferase (NNMT): a key enzyme in cancer metabolism and therapeutic target","volume":"142","author":"Sun","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.critrevonc.2026.105622_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1287421","article-title":"Exercise training upregulates intracellular nicotinamide phosphoribosyltransferase expression in humans: a systematic review with meta-analysis","volume":"11","author":"Sun","year":"2023","journal-title":"Front. Public. Health"},{"key":"10.1016\/j.critrevonc.2026.105622_bib75","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.200","article-title":"Nicotinamide N-methyltransferase expression in SH-SY5Y neuroblastoma and N27 mesencephalic neurones induces changes in cell morphology via ephrin-B2 and akt signalling","volume":"4","author":"Thomas","year":"2013","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.critrevonc.2026.105622_bib76","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/nchembio.1204","article-title":"NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink","volume":"9","author":"Ulanovskaya","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.critrevonc.2026.105622_bib77","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau0135","article-title":"T cell stemness and dysfunction in tumors are triggered by a common mechanism","volume":"363","author":"Vodnala","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2026.105622_bib78","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41419-022-04713-z","article-title":"Complex roles of nicotinamide N-methyltransferase in cancer progression","volume":"13","author":"Wang","year":"2022","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.critrevonc.2026.105622_bib79","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1038\/s41388-024-03112-2","article-title":"NNMT switches the proangiogenic phenotype of cancer-associated fibroblasts via epigenetically regulating ETS2\/VEGFA axis","volume":"43","author":"Wang","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2026.105622_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2024.117595","article-title":"Drug discovery targeting nicotinamide phosphoribosyltransferase (NAMPT): Updated progress and perspectives","volume":"99","author":"Wen","year":"2024","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.critrevonc.2026.105622_bib81","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.canlet.2013.08.014","article-title":"Molecular mechanisms underlying chronic inflammation-associated cancers","volume":"345","author":"Wu","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2026.105622_bib82","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1016\/j.apsb.2021.12.017","article-title":"NAMPT-targeting PROTAC promotes antitumor immunity via suppressing myeloid-derived suppressor cell expansion","volume":"12","author":"Wu","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.critrevonc.2026.105622_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107753","article-title":"Tumor microenvironment as a therapeutic target in cancer","volume":"221","author":"Xiao","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.critrevonc.2026.105622_bib84","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41392-020-00311-7","article-title":"NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential","volume":"5","author":"Xie","year":"2020","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.critrevonc.2026.105622_bib85","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.abb.2014.08.017","article-title":"Nicotinamide N-methyltransferase enhances the capacity of tumorigenesis associated with the promotion of cell cycle progression in human colorectal cancer cells","volume":"564","author":"Xie","year":"2014","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.critrevonc.2026.105622_bib86","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3389\/fonc.2018.00622","article-title":"NAD metabolism in cancer therapeutics","volume":"8","author":"Yaku","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105622_bib87","doi-asserted-by":"crossref","first-page":"37509","DOI":"10.1021\/acsomega.2c04286","article-title":"Nicotinamide N-Methyltransferase Remodeled Cell Metabolism and Aggravated Proinflammatory Responses by Activating STAT3\/IL1\u03b2\/PGE2 Pathway","volume":"7","author":"Yang","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.critrevonc.2026.105622_bib88","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009281","article-title":"NAD+ metabolism enzyme NNMT in cancer-associated fibroblasts drives tumor progression and resistance to immunotherapy by modulating macrophages in urothelial bladder cancer","volume":"12","author":"Yang","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105622_bib89","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70071","article-title":"Small extracellular vesicle-derived nicotinamide phosphoribosyltransferase (NAMPT) induces acyl-coenzyme a synthetase SLC27A4-mediated glycolysis to promote hepatocellular carcinoma","volume":"14","author":"Yeung","year":"2025","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.critrevonc.2026.105622_bib90","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.cmet.2017.11.002","article-title":"NAD+ intermediates: the biology and therapeutic potential of NMN and NR","volume":"27","author":"Yoshino","year":"2018","journal-title":"Cell. Metab."},{"key":"10.1016\/j.critrevonc.2026.105622_bib91","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2025-6921","article-title":"NAMPT inhibition impacts energy metabolism, induces DNA damage, and mediates tumor regression in preclinical neuroblastoma models","volume":"85","author":"Yu","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105622_bib92","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41568-023-00660-9","article-title":"Beyond genetics: driving cancer with the tumour microenvironment behind the wheel","volume":"24","author":"Yuan","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105622_bib93","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.pan.2013.01.001","article-title":"Nicotinamide prohibits proliferation and enhances chemosensitivity of pancreatic cancer cells through deregulating SIRT1 and ras\/akt pathways","volume":"13","author":"Zhang","year":"2013","journal-title":"Pancreatology"},{"key":"10.1016\/j.critrevonc.2026.105622_bib94","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.3390\/cancers15092427","article-title":"High-Dosage NMN Promotes Ferroptosis to Suppress Lung Adenocarcinoma Growth through the NAM-Mediated SIRT1-AMPK-ACC Pathway","volume":"15","author":"Zhang","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105622_bib95","article-title":"Novel carbamate-based o-aminobenzamide derivatives as potent antigastric carcinoma agents via disrupting NAD+ salvage synthesis","author":"Zhang","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.critrevonc.2026.105622_bib96","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41420-025-02672-w","article-title":"Nicotinamide phosphoribosyltransferase in NAD+ metabolism: physiological and pathophysiological implications","volume":"11","author":"Zhang","year":"2025","journal-title":"Cell. Death Discov."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826005093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826005093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:00:38Z","timestamp":1793088038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826005093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":96,"alternative-id":["S1040842826005093"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105622","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting nicotinamide metabolism to reprogram the tumor microenvironment: Mechanisms and novel therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105622","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105622"}}